Discovery & Development

Inhalers still don’t work as well as they should, but computational modeling is here to help.

Aging digital systems limit the potential of decentralized trials. It's time to rethink the technologies driving them.

How the Drugs for Neglected Diseases Initiative and the Malaysian government partnered to tackle hep C with an affordable, effective cure.

In the 20th century, physics and chemistry reshaped the world. Here’s why biology will be the game-changer in the 21st century.

Salicylanilides have been a reliable treatment against tapeworms for much of pharma’s history. Now, they could be used to help fight COVID-19.

The question that’s on everyone’s lips: how can developers tackle solid tumors and bring cell therapy to millions?

Google’s DeepMind has opened its AlphaFold protein structure database to the world.

Crowdsourcing initiative searches for a single-shot MRNA COVID-19 vaccine.

How a new 3D bioprinter could – quite literally – add a new dimension to drug screening and disease modeling.

Epigenetic switches are being used to identify the optimal combination of transcription factors required to derive clinically valuable cell types.